Cardiac Conduction Safety during Coadministration of Artemether-Lumefantrine and Lopinavir/Ritonavir in HIV-Infected Ugandan Adults.
about
Lopinavir/ritonavir significantly influences pharmacokinetic exposure of artemether/lumefantrine in HIV-infected Ugandan adultsThe interaction between artemether-lumefantrine and lopinavir/ritonavir-based antiretroviral therapy in HIV-1 infected patients.Development of an evidence evaluation and synthesis system for drug-drug interactions, and its application to a systematic review of HIV and malaria co-infectionClinical pharmacokinetic drug interactions associated with artemisinin derivatives and HIV-antivirals.
P2860
Cardiac Conduction Safety during Coadministration of Artemether-Lumefantrine and Lopinavir/Ritonavir in HIV-Infected Ugandan Adults.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Cardiac Conduction Safety duri ...... n HIV-Infected Ugandan Adults.
@ast
Cardiac Conduction Safety duri ...... n HIV-Infected Ugandan Adults.
@en
type
label
Cardiac Conduction Safety duri ...... n HIV-Infected Ugandan Adults.
@ast
Cardiac Conduction Safety duri ...... n HIV-Infected Ugandan Adults.
@en
prefLabel
Cardiac Conduction Safety duri ...... n HIV-Infected Ugandan Adults.
@ast
Cardiac Conduction Safety duri ...... n HIV-Infected Ugandan Adults.
@en
P2093
P2860
P50
P356
P1476
Cardiac Conduction Safety duri ...... n HIV-Infected Ugandan Adults.
@en
P2093
Concepta Merry
David Back
Marta Boffito
Mohammed Lamorde
Pauline Byakika-Kibwika
Violet Okaba-Kayom
Wilson B Nyakoojo
P2860
P304
P356
10.1155/2011/393976
P577
2011-04-07T00:00:00Z